Clinical trial
Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast…
NCT00159458 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00159458 |
|---|---|
| Title | Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer |
| Official title | Phase II Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer |
| Lead sponsor | University of Southern California, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Breast Cancer, Metastastic Breast Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine and oxaliplatin |
| Enrollment | 7 |
| Start date | Jul 1, 2003 |
| Primary completion | Nov 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: